ATOSSA - Clinical trial • Breast Cancer Foundation NZ

Donate to save lives this Breast Cancer Awareness Month.

ATOSSA

Early Breast Cancer clinical trials for ER+

Recruiting
Updated: June 30, 2020

The purpose of this study is to examine the action of a new medication (called “(Z)-endoxifen”) in patients with breast cancer.

The purpose of this study is to examine the action of a new medication (called “(Z)-endoxifen”) in patients with breast cancer.

Who is it for?

You may be eligible for this study if you are aged 18 or older and are scheduled to undergo mastectomy or lumpectomy for invasive breast cancer

Study details

All participants in this study will take oral capsules of the study medication for at least 21 days and up to the day of their surgery. Before and after treatment, participants will provide a tumour biopsy and blood sample. Additionally, participants will need to consent to their removed tissue being tested.

It is hoped this research will provide information regarding the action of (Z)-endoxifen and potentially lead to new therapeutics for breast cancer.

For full trial information

Australia



Contact:

Devon Payne

If you think you might be a candidate for this trial, use the contact details supplied, or talk to your doctor.

Want to access a trial that's not in your area? It's not always possible, but if you're interested, email us at intouch@bcf.org.nz

Similar clinical trials

For Early Breast Cancer, Supportive Care

Are we out of date? If you have updated or new information about a trial, we’d be grateful if you’d share it with us – email your update to intouch@bcf.org.nz

Find clinical trials

Interested in a clinical trial?

Subscribe for updates & stay in the loop with new studies.